Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
UNKNOWN
NCT05274204
Individual Patient Expanded Access to CA102N
Sponsor: Holy Stone Healthcare Co., Ltd
View on ClinicalTrials.gov
Summary
This study is an individual patient expanded access protocol that the subject enrolled had completed the combination treatment of CA102N plus Lonsurf for at least 12 cycles.
Official title: Expanded Access to CA102N in One Patient Who Completed at Least 12 Cycles of Combination Therapy of CA102N Plus Lonsurf in Clinical Study Number of HS-CA102N-101
Key Details
Gender
Not specified
Age Range
Any - Any
Study Type
EXPANDED_ACCESS
Enrollment
Not specified
Start Date
Not specified
Completion Date
Not specified
Last Updated
2026-09-18
Healthy Volunteers
Not specified
Interventions
DRUG
CA102N